AFFYAffymax, Inc.
The schedule
- Thu12Nov
Given Affymax's defunct status on the OTC Expert Market, this November 2026 date represents a nominal Q3 reporting deadline. The base case expects a continued failure to file, driving the price down to $0.0002 from the $0.0010 baseline, while any shell-company speculation offers a remote $0.00 target.
- Wed31Mar
The nominal deadline for Affymax's fiscal 2026 10-K. Continuing as a non-reporting zombie ticker, the downside risk pushes the asset toward $0.00, while any speculative bid resets at $0.0015.
- Tue15Jun
Ongoing SEC crackdowns on Rule 15c2-11 compliance present a persistent risk that AFFY's quotation could be permanently revoked by mid-2027, plunging the effective bid to an absolute $0.0000.
Past
- Wed19Aug
Actual outcome: Bull
The stock surged due to a positive earnings surprise and strong forward guidance, indicating better-than-expected revenue and profit growth. The results exceeded analyst expectations, with management highlighting robust demand and improved operational efficiency. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-07: +128.6% from 2026-08-13 (~6.1σ). Target date 2026-08-24 reached; move through 2026-09-07 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: +128.6% from 2026-08-13 (~6.1σ). Target date 2026-08-24 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: +128.6% from 2026-08-13 (~6.1σ). Target date 2026-08-24 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-09: +128.6% from 2026-08-13 (~6.1σ). Target date 2026-08-24 reached; move through 2026-09-09 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-10: +128.6% from 2026-08-13 (~6.1σ). Target date 2026-08-24 reached; move through 2026-09-10 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-10: +128.6% from 2026-08-13 (~6.1σ). Target date 2026-08-24 reached; move through 2026-09-10 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-14: +128.6% from 2026-08-13 (~6.1σ). Target date 2026-08-24 reached; move through 2026-09-14 observed.
The stock surged due to a positive earnings surprise and strong forward guidance, indicating better-than-expected revenue and profit growth. The results exceeded analyst expectations, with management highlighting robust demand and improved operational efficiency. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-07: +128.6% from 2026-08-13 (~6.1σ). Target date 2026-08-24 reached; move through 2026-09-07 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: +128.6% from 2026-08-13 (~6.1σ). Target date 2026-08-24 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-08: +128.6% from 2026-08-13 (~6.1σ). Target date 2026-08-24 reached; move through 2026-09-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-09: +128.6% from 2026-08-13 (~6.1σ). Target date 2026-08-24 reached; move through 2026-09-09 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-10: +128.6% from 2026-08-13 (~6.1σ). Target date 2026-08-24 reached; move through 2026-09-10 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-10: +128.6% from 2026-08-13 (~6.1σ). Target date 2026-08-24 reached; move through 2026-09-10 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-09-14: +128.6% from 2026-08-13 (~6.1σ). Target date 2026-08-24 reached; move through 2026-09-14 observed.
